Janice M. Darden

1.2k total citations
16 papers, 349 citations indexed

About

Janice M. Darden is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Janice M. Darden has authored 16 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Virology. Recurrent topics in Janice M. Darden's work include HIV Research and Treatment (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and SARS-CoV-2 detection and testing (3 papers). Janice M. Darden is often cited by papers focused on HIV Research and Treatment (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and SARS-CoV-2 detection and testing (3 papers). Janice M. Darden collaborates with scholars based in United States, Thailand and South Africa. Janice M. Darden's co-authors include M. Patricia D’Souza, Victoria R. Polonis, Deborah L. Birx, Isaac R. Rodriguez‐Chavez, R. Hitchcock, Mark de Souza, Eric Sanders‐Buell, Sodsai Tovanabutra, Bruce K. Brown and Julie Frost and has published in prestigious journals such as PLoS ONE, Journal of Virology and Frontiers in Immunology.

In The Last Decade

Janice M. Darden

14 papers receiving 342 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Janice M. Darden 154 121 104 71 67 16 349
Claudia Goulston 200 1.3× 151 1.2× 129 1.2× 53 0.7× 84 1.3× 10 374
A. Rudent 99 0.6× 97 0.8× 166 1.6× 41 0.6× 135 2.0× 16 348
Michele Milanese 55 0.4× 47 0.4× 132 1.3× 82 1.2× 64 1.0× 18 318
Ria Goswami 66 0.4× 115 1.0× 104 1.0× 52 0.7× 89 1.3× 19 300
Eva Stylianou 201 1.3× 97 0.8× 214 2.1× 59 0.8× 94 1.4× 12 411
Peter Gowland 81 0.5× 160 1.3× 40 0.4× 57 0.8× 114 1.7× 36 404
Mayumi Imahashi 184 1.2× 204 1.7× 83 0.8× 169 2.4× 103 1.5× 26 401
Wang Hj 257 1.7× 157 1.3× 138 1.3× 63 0.9× 190 2.8× 12 484
Troels Bygum Knudsen 126 0.8× 116 1.0× 159 1.5× 62 0.9× 134 2.0× 17 447
Chin-Yih Ou 220 1.4× 252 2.1× 61 0.6× 83 1.2× 176 2.6× 8 541

Countries citing papers authored by Janice M. Darden

Since Specialization
Citations

This map shows the geographic impact of Janice M. Darden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice M. Darden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice M. Darden more than expected).

Fields of papers citing papers by Janice M. Darden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice M. Darden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice M. Darden. The network helps show where Janice M. Darden may publish in the future.

Co-authorship network of co-authors of Janice M. Darden

This figure shows the co-authorship network connecting the top 25 collaborators of Janice M. Darden. A scholar is included among the top collaborators of Janice M. Darden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice M. Darden. Janice M. Darden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bedno, Sheryl A., Shilpa Hakre, Shannon Clark, et al.. (2023). Prospective screening for sexually transmitted infections among US service members with Chlamydia trachomatis or Neisseria gonorrhoeae infection. PLoS ONE. 18(1). e0280783–e0280783.
2.
Gromowski, Gregory D., Sandra V. Mayer, Isabella Swafford, et al.. (2023). Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military population. EBioMedicine. 94. 104683–104683. 4 indexed citations
3.
Lakhal-Naouar, Inès, Holly R. Hack, Janice M. Darden, et al.. (2023). Analytical validation of quantitative SARS-CoV-2 subgenomic and viral load laboratory developed tests conducted on the Panther Fusion® (Hologic) with preliminary application to clinical samples. PLoS ONE. 18(6). e0287576–e0287576. 1 indexed citations
4.
Chandrasekaran, Prabha, Inès Lakhal-Naouar, Kristina K. Peachman, et al.. (2022). Validation of SARS-CoV-2 pooled testing for surveillance using the Panther Fusion® system: Impact of pool size, automation, and assay chemistry. PLoS ONE. 17(11). e0276729–e0276729. 1 indexed citations
5.
Wieczorek, Lindsay, Michelle Zemil, Vincent Dussupt, et al.. (2022). Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection. Frontiers in Immunology. 13. 901217–901217. 6 indexed citations
6.
Chaudhury, Sidhartha, Jack Hutter, Shilpa Hakre, et al.. (2021). Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform. PLoS ONE. 16(6). e0252628–e0252628. 8 indexed citations
7.
Godfrey, Catherine, Pamela Michelow, Vikrant V. Sahasrabuddhe, et al.. (2013). Improving Diagnostic Capability for HPV Disease Internationally Within the NIH-NIAID Division of AIDS Clinical Trial Networks. American Journal of Clinical Pathology. 140(6). 881–889. 6 indexed citations
8.
Eller, Michael A., Bonnie M. Slike, Josephine H. Cox, et al.. (2011). A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells. PLoS ONE. 6(9). e24254–e24254. 9 indexed citations
9.
Jaimes, María C., Holden T. Maecker, Ming Yan, et al.. (2010). Quality assurance of intracellular cytokine staining assays: Analysis of multiple rounds of proficiency testing. Journal of Immunological Methods. 363(2). 143–157. 27 indexed citations
10.
Rodriguez‐Chavez, Isaac R., et al.. (2007). Guidelines on good clinical laboratory practice: Bridging operations between research and clinical research laboratories. Journal of Pharmaceutical and Biomedical Analysis. 46(1). 18–29. 100 indexed citations
11.
Jaimes, Maria, Janice M. Darden, Patricia D’Souza, & Holden T. Maecker. (2007). Standardization and Quality Assurance of Cytokine Flow Cytometry Assays. Clinical Immunology. 123. S58–S58. 7 indexed citations
13.
Polonis, Victoria R., Mark de Souza, Janice M. Darden, et al.. (2003). Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Resistance Is Associated with the Syncytium-Inducing Phenotype and Lower CD4 Cell Counts in Subtype CRF01_AE-Infected Patients. Journal of Virology. 77(15). 8570–8576. 9 indexed citations
14.
Darden, Janice M., Victoria R. Polonis, Mark S. deSouza, et al.. (2000). A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates. Cytometry. 40(2). 141–150. 24 indexed citations
15.
Pattanapanyasat, Kovit, Charin Thepthai, Surada Lerdwana, et al.. (2000). Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry. 42(1). 11–17. 37 indexed citations
16.
Pattanapanyasat, Kovit, Charin Thepthai, Surada Lerdwana, et al.. (2000). Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry. 42(1). 11–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026